{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-000427","form_type":"8-K","ticker":null,"cik":"0001708331","company_name":"Virpax Pharmaceuticals, Inc.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.527087+00:00","generated_at":"2026-05-24T08:47:17.527424+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Virpax Pharmaceuticals effects 1-for-25 reverse stock split effective March 21, 2025","bullets":["Reverse split ratio set at 1-for-25, effective 12:01 a.m. ET on March 21, 2025.","Outstanding shares reduced from 31,062,581 to 1,242,504.","Trading symbol VRPX unchanged; new CUSIP 928251305.","Board approved final ratio on March 5, 2025, following stockholder authorization on January 15, 2025.","Equity awards and warrants proportionally adjusted for the split."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-000427","json":"https://secwatch.observer/filing/0001731122-25-000427.json","markdown":"https://secwatch.observer/filing/0001731122-25-000427.md","text":"https://secwatch.observer/filing/0001731122-25-000427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/0001731122-25-000427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/e6439_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:47:17.527424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a114f7d8408e39398a829df0d1d09f91ee1ff8e","claim":"Virpax Pharmaceuticals, Inc.: Filed a Certificate of Amendment to effect a 1-for-25 reverse stock split of common stock (effective 2025-03-21).","evidence_excerpt":"On March 12, 2025, Virpax Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”) to effect a 1-for-25 reverse stock split","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708331/000173112225000427/0001731122-25-000427-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-03-21"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}